{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["7-\u03b1-Hydroxyfrullanolide", "DNA damage response", "G1 arrest", "G2/M arrest", "Microtubules", "Molecular docking", "Natural product", "Sesquiterpene lactones", "Triple-negative breast cancer"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35651747", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "16"}, "DateRevised": {"Year": "2023", "Month": "01", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "27"}], "Language": ["eng"], "ELocationID": ["e13508", "10.7717/peerj.13508"], "Journal": {"ISSN": "2167-8359", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2022"}}, "Title": "PeerJ", "ISOAbbreviation": "PeerJ"}, "ArticleTitle": "Anticancer mechanism of 7-\u03b1-hydroxyfrullanolide on microtubules and computational prediction of its target binding in triple-negative breast cancer cells.", "Pagination": {"StartPage": "e13508", "MedlinePgn": "e13508"}, "Abstract": {"AbstractText": ["Triple-negative breast cancer (TNBC) responds poorly to the available drugs; thus, the mortality rate associated with TNBC remains high. 7-\u03b1-Hydroxyfrullanolide (7HF) possesses anticancer properties and arrests cells in the G2/M-phase via modulation of several proteins involved in the G2/M-phase transition, as well as the mitotic checkpoint in MDA-MB-468 (TNBC) cells. Microtubules (MTs) dynamically regulate cell division in the G2/M phase and are related to cancer cell stress response. However, antimitotic drug cytotoxicity to multiple cancer resistance developed in response to drugs are obstacles faced to date. Here, the activity and mechanism via which 7HF controls MTs dynamics was investigated in MDA-MB-468 cells.", "7HF uptake by MDA-MB-468 cells was assessed using spectrophotometry. The drug-like properties of 7HF were predicted using the Swiss-absorption, distribution, metabolism, and excretion (ADME) webtool. Then, the effect of 7HF treatment (6, 12, and 24 \u00b5M) on the dynamic arrangement of MTs was assessed for 1, 12, and 24 h using indirect immunofluorescence. Polymerization of \u03b1- and \u03b2-tubulin was assessed using different 7HF concentrations in a cell-free system for 1 h. Cell proliferation assay with bromodeoxyuridine plus propidium iodide staining and flow cytometry was performed at different 7HF concentrations and time points. The mechanism of action was assessed by detecting the expression of proteins, including Bub3, cyclin B1, p-Cdk1 (Tyr15), Rb, p-Rb (Ser780), Chk1, p-Chk1 (Ser345), Chk2, p-Chk2 (Ser516), and p-H2AX (Ser139), using western blotting. Molecular docking was used to predict the molecular interactions between 7HF and tubulins in MTs.", "We observed that 7HF was able to enter the MDA-MB-468 cells. The ADME webtool analysis predicted that it possesses the high passive permeation and gastrointestinal absorption properties of drugs. Various concentrations of 7HF disrupted the dynamic arrangement of spindle MTs by causing radial spindle array shrinkage and expansion of fibrous spindle density and radial array lengths in a time-dependent manner. 7HF reduced polymerization of \u03b1-, \u03b2-tubulin in dose-dependent manner. 7HF also triggered DNA damage response by inducing G2/M and G1 phase arrests in a concentration and time-dependent manner, which occurred due to the upregulation of Bub3, Chk1, p-Chk1 (Ser345), p-Cdk1 (Tyr15), and cyclin B1. According to molecular docking analysis, 7HF preferred to bind to \u03b2-tubulin over \u03b1-tubulin. The lactone, ketone, and hydroxyl groups of 7HF supported the 7HF-tubulin interactions. Hydrogen bonding with a hydrocarbon ring and salt bridge attractive forces were responsible for the binding versatility of 7HF.", "This is the first study to investigate the molecular mechanism, MTs interacting sites, and the internalization and drug-like properties of 7HF in TNBC cells. The findings will be useful for developing 7HF-based treatment for patients with TNBC."], "CopyrightInformation": "\u00a92022 Chimplee et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand."}], "LastName": "Chimplee", "ForeName": "Siriphorn", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biosciences, University of Sheffield, Sheffield, United Kingdom."}], "LastName": "Smythe", "ForeName": "Carl", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand."}], "LastName": "Tipmanee", "ForeName": "Varomyalin", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Excellence in DNA Barcoding of Thai Medicinal Plants, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand."}], "LastName": "Sukrong", "ForeName": "Suchada", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand."}], "LastName": "Kanokwiroon", "ForeName": "Kanyanatt", "Initials": "K"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PeerJ", "NlmUniqueID": "101603425", "ISSNLinking": "2167-8359"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cyclin B1"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cyclin B1"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Triple Negative Breast Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Tubulin"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Microtubules"}], "CoiStatement": "The authors declare there are no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Adasme MF, Linnemann KL, Bolz SN, Kaiser F, Salentin S, Haupt VJ, Schroeder M. PLIP 2021: expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA. Nucleic Acids Research. 2021;49:W530\u2013W534. doi: 10.1093/nar/gkab294.", "ArticleIdList": ["10.1093/nar/gkab294", "PMC8262720", "33950214"]}, {"Citation": "Atta ur R, Choudhary MI, Ata A, Alam M, Farooq A, Perveen S, Shekhani MS, Ahmed N. Microbial transformations of 7\u03b1-hydroxyfrullanolide. The Journal of Natural Products. 1994;57:1251\u20131255. doi: 10.1021/np50111a010.", "ArticleIdList": ["10.1021/np50111a010"]}, {"Citation": "Avila J. Microtubule functions. Life Science. 1992;50:327\u2013334. doi: 10.1016/0024-3205(92)90433-p.", "ArticleIdList": ["10.1016/0024-3205(92)90433-p", "1732704"]}, {"Citation": "Ba\u00f1uelos Hern\u00e1ndez AE, Mendoza-Espinoza JA, Pereda-Miranda R, Cerda-Garc\u00eda-Rojas CM. Studies of (\u2212)-pironetin binding to \u03b1-tubulin: conformation, docking, and molecular dynamics. The Journal of Organic Chemistry. 2014;79:3752\u20133764. doi: 10.1021/jo500420j.", "ArticleIdList": ["10.1021/jo500420j", "24761989"]}, {"Citation": "Barasoain I, Garcia-Carril AM, Matesanz R, Maccari G, Trigili C, Mori M, Shi JZ, Fang WS, Andreu JM, Botta M, Diaz JF. Probing the pore drug binding site of microtubules with fluorescent taxanes: evidence of two binding poses. Chemistry & Biology. 2010;17:243\u2013253. doi: 10.1016/j.chembiol.2010.02.006.", "ArticleIdList": ["10.1016/j.chembiol.2010.02.006", "20338516"]}, {"Citation": "Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of triple-negative breast cancer\u2014expanded options, evolving needs. Nature Reviews Clinical Oncology. 2021;19:91\u2013113. doi: 10.1038/s41571-021-00565-2.", "ArticleIdList": ["10.1038/s41571-021-00565-2", "34754128"]}, {"Citation": "Blajeski AL, Phan VA, Kottke TJ, Kaufmann SH. G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells. Journal Clinical Investigation. 2002;110:91\u201399. doi: 10.1172/JCI13275.", "ArticleIdList": ["10.1172/JCI13275", "PMC151025", "12093892"]}, {"Citation": "Bocca C, Gabriel L, Bozzo F, Miglietta A. A sesquiterpene lactone, costunolide, interacts with microtubule protein and inhibits the growth of MCF-7 cells. Chemicobiological Interactions. 2004;147:79\u201386. doi: 10.1016/j.cbi.2003.10.008.", "ArticleIdList": ["10.1016/j.cbi.2003.10.008", "14726154"]}, {"Citation": "Bosco A, Golsteyn RM. Emerging anti-mitotic activities and other bioactivities of sesquiterpene compounds upon human cells. Molecules. 2017;22:459. doi: 10.3390/molecules22030459.", "ArticleIdList": ["10.3390/molecules22030459", "PMC6155193", "28335397"]}, {"Citation": "Bosco A, Molina L, Kerneis SM, Hatzopoulos G, Favez T, Gonczy P, Tantapakul C, Maneerat W, Yeremy B, Williams DE, Andersen RJ, Golsteyn RM. Pulchelloid A, a sesquiterpene lactone from the Canadian prairie plant Gaillardia aristata inhibits mitosis in human cells. Molecular Biology Reports. 2021;48:5459\u20135471. doi: 10.1007/s11033-021-06554-z.", "ArticleIdList": ["10.1007/s11033-021-06554-z", "34304367"]}, {"Citation": "Caldas LA, Horvath RO, Ferreira-Silva GA, Ferreira MJP, Ionta M, Sartorelli P. Calein C, a sesquiterpene lactone isolated from Calea pinnatifida (Asteraceae), inhibits mitotic progression and induces apoptosis in MCF-7 cells. Frontiers in Pharmacology. 2018;9:1191. doi: 10.3389/fphar.2018.01191.", "ArticleIdList": ["10.3389/fphar.2018.01191", "PMC6201056", "30405412"]}, {"Citation": "Cecchini MJ, Amiri M, Dick FA. Analysis of cell cycle position in mammalian cells. The Journal of Visualized Experiments. 2012;59:3941. doi: 10.3791/3491.", "ArticleIdList": ["10.3791/3491", "PMC3462567", "22297617"]}, {"Citation": "Champoux JJ. DNA topoisomerases: structure, function, and mechanism. Annual Review of Biochemistry. 2001;70:369\u2013413. doi: 10.1146/annurev.biochem.70.1.369.", "ArticleIdList": ["10.1146/annurev.biochem.70.1.369", "11395412"]}, {"Citation": "Chavez KJ, Garimella SV, Lipkowitz S. Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. Breast Disease. 2010;32:35\u201348. doi: 10.3233/BD-2010-0307.", "ArticleIdList": ["10.3233/BD-2010-0307", "PMC3532890", "21778573"]}, {"Citation": "Chimplee S, Graidist P, Srisawat T, Sukrong S, Bissanum R, Kanokwiroon K. Anti-breast cancer potential of frullanolide from Grangea maderaspatana plant by inducing apoptosis. Oncology Letters. 2019;17:5283\u20135291. doi: 10.3892/ol.2019.10209.", "ArticleIdList": ["10.3892/ol.2019.10209", "PMC6507448", "31186745"]}, {"Citation": "Chimplee S, Roytrakul S, Sukrong S, Srisawat T, Graidist P, Kanokwiroon K. Anticancer effects and molecular action of 7-\u03b1-hydroxyfrullanolide in G2/M-phase arrest and apoptosis in triple negative breast cancer cells. Molecules. 2022;27:407. doi: 10.3390/molecules27020407.", "ArticleIdList": ["10.3390/molecules27020407", "PMC8779136", "35056723"]}, {"Citation": "Cotugno R, Fortunato R, Santoro A, Gallotta D, Braca A, De Tommasi N, Belisario MA. Effect of sesquiterpene lactone coronopilin on leukaemia cell population growth, cell type-specific induction of apoptosis and mitotic catastrophe. Cell Proliferation. 2012;45:53\u201365. doi: 10.1111/j.1365-2184.2011.00796.x.", "ArticleIdList": ["10.1111/j.1365-2184.2011.00796.x", "PMC6496441", "22168177"]}, {"Citation": "Coulup SK, Georg GI. Revisiting microtubule targeting agents: alpha-tubulin and the pironetin binding site as unexplored targets for cancer therapeutics. Bioorganic & Medicinal Chemistry Letters. 2019;29:1865\u20131873. doi: 10.1016/j.bmcl.2019.05.042.", "ArticleIdList": ["10.1016/j.bmcl.2019.05.042", "31130264"]}, {"Citation": "Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports. 2017;7:42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "De Ruijter TC, Veeck J, De Hoon JP, Van Engeland M, Tjan-Heijnen VC. Characteristics of triple-negative breast cancer. The Journal of Cancer Research and Clinical Oncology. 2011;137:183\u2013192. doi: 10.1007/s00432-010-0957-x.", "ArticleIdList": ["10.1007/s00432-010-0957-x", "PMC3018596", "21069385"]}, {"Citation": "Duangmano S, Sae-Lim P, Suksamrarn A, Domann FE, Patmasiriwat P. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation. BMC Complementary and Alternative Medicine. 2012;12:185. doi: 10.1186/1472-6882-12-185.", "ArticleIdList": ["10.1186/1472-6882-12-185", "PMC3527297", "23062075"]}, {"Citation": "Dumontet C, Jordan MA. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nature Reviews Drug Discovery. 2010;9:790\u2013803. doi: 10.1038/nrd3253.", "ArticleIdList": ["10.1038/nrd3253", "PMC3194401", "20885410"]}, {"Citation": "Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pineros M, Znaor A, Bray F. Cancer statistics for the year 2020: an overview. International Journal of Cancer. 2021;149:778\u2013789. doi: 10.1002/ijc.33588.", "ArticleIdList": ["10.1002/ijc.33588", "33818764"]}, {"Citation": "Field Jessica J, D\u00edaz Jos\u00e9 F, Miller John H. The binding sites of microtubule-stabilizing agents. Chemistry & Biology. 2013;20:301\u2013315. doi: 10.1016/j.chembiol.2013.01.014.", "ArticleIdList": ["10.1016/j.chembiol.2013.01.014", "23521789"]}, {"Citation": "Fonseca LC, Dadarkar SS, Lobo AS, Suthar AC, Chauhan VS, Chandrababu S, Sharma SD, Dagia NM, Padigaru M. 7-hydroxyfrullanolide, a sesquiterpene lactone, inhibits pro-inflammatory cytokine production from immune cells and is orally efficacious in animal models of inflammation. European Journal of Pharmacology. 2010;644:220\u2013229. doi: 10.1016/j.ejphar.2010.06.052.", "ArticleIdList": ["10.1016/j.ejphar.2010.06.052", "20621086"]}, {"Citation": "Gallagher J, Brian M. Microtubule-stabilizing natural products as promising cancer therapeutics. Current Medicinal Chemistry. 2007;14:2959\u20132967. doi: 10.2174/092986707782794014.", "ArticleIdList": ["10.2174/092986707782794014", "18220732"]}, {"Citation": "Garcia V, Lara-Chica M, Cantarero I, Sterner O, Calzado MA, Munoz E. Galiellalactone induces cell cycle arrest and apoptosis through the ATM/ATR pathway in prostate cancer cells. Oncotarget. 2016;7:4490\u20134506. doi: 10.18632/oncotarget.6606.", "ArticleIdList": ["10.18632/oncotarget.6606", "PMC4826221", "26683224"]}, {"Citation": "Gascoigne KE, Taylor SS. How do anti-mitotic drugs kill cancer cells? The Journal of Cell Science. 2009;122:2579\u20132585. doi: 10.1242/jcs.039719.", "ArticleIdList": ["10.1242/jcs.039719", "19625502"]}, {"Citation": "Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA, Darwiche N. What made sesquiterpene lactones reach cancer clinical trials? Drug Discovery Today. 2010;15:668\u2013678. doi: 10.1016/j.drudis.2010.06.002.", "ArticleIdList": ["10.1016/j.drudis.2010.06.002", "20541036"]}, {"Citation": "Ghelli Luserna di Ror\u00e0 A, Cerchione C, Martinelli G, Simonetti G. A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target. The Journal of Hematology & Oncology. 2020;13:126. doi: 10.1186/s13045-020-00959-2.", "ArticleIdList": ["10.1186/s13045-020-00959-2", "PMC7507691", "32958072"]}, {"Citation": "Gigant B, Wang C, Ravelli RBG, Roussi F, Steinmetz MO, Curmi PA, Sobel A, Knossow M. Structural basis for the regulation of tubulin by vinblastine. Nature. 2005;435:519\u2013522. doi: 10.1038/nature03566.", "ArticleIdList": ["10.1038/nature03566", "15917812"]}, {"Citation": "Gudimchuk NB, McIntosh JR. Regulation of microtubule dynamics, mechanics and function through the growing tip. Nature Reviews Molecular Cell Biology. 2021;22:777\u2013795. doi: 10.1038/s41580-021-00399-x.", "ArticleIdList": ["10.1038/s41580-021-00399-x", "34408299"]}, {"Citation": "Han JS, Vitre B, Fachinetti D, Cleveland DW. Bimodal activation of BubR1 by Bub3 sustains mitotic checkpoint signaling. Proceedings of the National Academy of Sciences of the United States of America. 2014;111:E4185\u2013E4193. doi: 10.1073/pnas.1416277111.", "ArticleIdList": ["10.1073/pnas.1416277111", "PMC4210015", "25246557"]}, {"Citation": "Humphrey W, Dalke A, Schulten K. VMD: Visual molecular dynamics. The Journal of Molecular Graphics. 1996;14:33\u201338. doi: 10.1016/0263-7855(96)00018-5.", "ArticleIdList": ["10.1016/0263-7855(96)00018-5", "8744570"]}, {"Citation": "Jackman M. G2/M transition. In: Schwab M, editor. Encyclopedia of cancer. Berlin, Heidelberg: Springer; 2011. pp. 1482\u20131484."}, {"Citation": "Ju J-Q, Li X-H, Pan M-H, Xu Y, Sun M-H, Xu Y, Sun S-C. CHK1 monitors spindle assembly checkpoint and DNA damage repair during the first cleavage of mouse early embryos. Cell Proliferation. 2020;53:e12895. doi: 10.1111/cpr.12895.", "ArticleIdList": ["10.1111/cpr.12895", "PMC7574881", "32914523"]}, {"Citation": "Kellogg EH, Hejab NMA, Howes S, Northcote P, Miller JH, Diaz JF, Downing KH, Nogales E. Insights into the distinct mechanisms of action of taxane and non-taxane microtubule stabilizers from cryo-EM structures. The Journal of Molecular Biology. 2017;429:633\u2013646. doi: 10.1016/j.jmb.2017.01.001.", "ArticleIdList": ["10.1016/j.jmb.2017.01.001", "PMC5325780", "28104363"]}, {"Citation": "Kousholt AN, Menzel T, Sorensen CS. Pathways for genome integrity in G2 phase of the cell cycle. Biomolecules. 2012;2:579\u2013607. doi: 10.3390/biom2040579.", "ArticleIdList": ["10.3390/biom2040579", "PMC4030857", "24970150"]}, {"Citation": "Lehmann BD, Pietenpol JA. Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes. The Journal of Pathology. 2014;232:142\u2013150. doi: 10.1002/path.4280.", "ArticleIdList": ["10.1002/path.4280", "PMC4090031", "24114677"]}, {"Citation": "Liao GS, Apaya MK, Shyur LF. Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy. Evidence-based Complementary Alternative Medicine. 2013;2013:437948. doi: 10.1155/2013/437948.", "ArticleIdList": ["10.1155/2013/437948", "PMC3694462", "23840256"]}, {"Citation": "Lindqvist A, Rodriguez-Bravo V, Medema RH. The decision to enter mitosis: feedback and redundancy in the mitotic entry network. The Journal of Cell Biology. 2009;185:193\u2013202. doi: 10.1083/jcb.200812045.", "ArticleIdList": ["10.1083/jcb.200812045", "PMC2700378", "19364923"]}, {"Citation": "Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews. 2001;46:3\u201326. doi: 10.1016/s0169-409x(00)00129-0.", "ArticleIdList": ["10.1016/s0169-409x(00)00129-0", "11259830"]}, {"Citation": "Liu CY, Chang HS, Chen IS, Chen CJ, Hsu ML, Fu SL, Chen YJ. Costunolide causes mitotic arrest and enhances radiosensitivity in human hepatocellular carcinoma cells. Radiation Oncology. 2011a;6:56. doi: 10.1186/1748-717X-6-56.", "ArticleIdList": ["10.1186/1748-717X-6-56", "PMC3123574", "21624128"]}, {"Citation": "Liu Y, Chen XQ, Liang HX, Zhang FX, Zhang B, Jin J, Chen YL, Cheng YX, Zhou GB. Small compound 6-O-angeloylplenolin induces mitotic arrest and exhibits therapeutic potentials in multiple myeloma. PLOS ONE. 2011b;6:e21930. doi: 10.1371/journal.pone.0021930.", "ArticleIdList": ["10.1371/journal.pone.0021930", "PMC3130785", "21755010"]}, {"Citation": "Liu ST, Zhang H. The mitotic checkpoint complex (MCC): looking back and forth after 15 years. AIMS Molecular Science. 2016;3:597\u2013634. doi: 10.3934/molsci.2016.4.597.", "ArticleIdList": ["10.3934/molsci.2016.4.597", "PMC5597056", "28920074"]}, {"Citation": "Lobert S, Fahy J, Hill BT, Duflos A, Etievant C, Correia JJ. Vinca alkaloid-induced tubulin spiral formation correlates with cytotoxicity in the leukemic L1210 cell line. Biochemistry. 2000;39:12053\u201312062. doi: 10.1021/bi001038r.", "ArticleIdList": ["10.1021/bi001038r", "11009620"]}, {"Citation": "Lottersberger F, Karssemeijer RA, Dimitrova N, De Lange T. 53BP1 and the LINC complex promote microtubule-dependent DSB mobility and DNA repair. Cell. 2015;163:880\u2013893. doi: 10.1016/j.cell.2015.09.057.", "ArticleIdList": ["10.1016/j.cell.2015.09.057", "PMC4636737", "26544937"]}, {"Citation": "Ma G, Chong L, Li Z, Cheung AH, Tattersall MH. Anticancer activities of sesquiterpene lactones from Cyathocline purpurea in vitro. Cancer Chemotherapy and Pharmacology. 2009;64:143\u2013152. doi: 10.1007/s00280-008-0863-y.", "ArticleIdList": ["10.1007/s00280-008-0863-y", "18998133"]}, {"Citation": "Ma S, Rong Z, Liu C, Qin X, Zhang X, Chen Q. DNA damage promotes microtubule dynamics through a DNA-PK-AKT axis for enhanced repair. The Journal of Cell Biology. 2021;220:e201911025. doi: 10.1083/jcb.201911025.", "ArticleIdList": ["10.1083/jcb.201911025", "PMC7791344", "33404607"]}, {"Citation": "Manchado E, Guillamot M, Malumbres M. Killing cells by targeting mitosis. Cell Death and Differentiation. 2012;19:369\u2013377. doi: 10.1038/cdd.2011.197.", "ArticleIdList": ["10.1038/cdd.2011.197", "PMC3278741", "22223105"]}, {"Citation": "Matthews HK, Bertoli C, De Bruin RAM. Cell cycle control in cancer. Nature Reviews Molecular Cell Biology. 2021;23:74\u201388. doi: 10.1038/s41580-021-00404-3.", "ArticleIdList": ["10.1038/s41580-021-00404-3", "34508254"]}, {"Citation": "Mitra A, Sept D. Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin. Biochemistry. 2004;43:13955\u201313962. doi: 10.1021/bi0487387.", "ArticleIdList": ["10.1021/bi0487387", "15518544"]}, {"Citation": "Molina L, Williams DE, Andersen RJ, Golsteyn RM. Isolation of a natural product with anti-mitotic activity from a toxic Canadian prairie plant. Heliyon. 2021;7:e07131. doi: 10.1016/j.heliyon.2021.e07131.", "ArticleIdList": ["10.1016/j.heliyon.2021.e07131", "PMC8167235", "34095597"]}, {"Citation": "Mollinedo F, Gajate C. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis. 2003;8:413\u2013450. doi: 10.1023/a:1025513106330.", "ArticleIdList": ["10.1023/a:1025513106330", "12975575"]}, {"Citation": "Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. The Journal of Computational Chemistry. 2009;30:2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Mukhtar E, Adhami VM, Mukhtar H. Targeting microtubules by natural agents for cancer therapy. Molecular Cancer Therapeutics. 2014;13:275\u2013284. doi: 10.1158/1535-7163.MCT-13-0791.", "ArticleIdList": ["10.1158/1535-7163.MCT-13-0791", "PMC3946048", "24435445"]}, {"Citation": "Nahata A, Saxena A, Suri N, Saxena AK, Dixit VK. Sphaeranthus indicus induces apoptosis through mitochondrial-dependent pathway in HL-60 cells and exerts cytotoxic potential on several human cancer cell lines. Integrative Cancer Therapies. 2013;12:236\u2013247. doi: 10.1177/1534735412451997.", "ArticleIdList": ["10.1177/1534735412451997", "22914874"]}, {"Citation": "Nunez Abad M, Calabuig-Farinas S, Lobo de Mena M, Jose Godes Sanz de Bremond M, Garcia Gonzalez C, Torres Martinez S, Garcia-Garcia JA, Iranzo Gonzalez-Cruz V, Camps Herrero C. Update on systemic treatment in early triple negative breast cancer. Therapeutic Advances in Medical Oncology. 2021;13:1758835920986749. doi: 10.1177/1758835920986749.", "ArticleIdList": ["10.1177/1758835920986749", "PMC7871289", "33613695"]}, {"Citation": "Pandey P, Singh D, Hasanain M, Ashraf R, Maheshwari M, Choyal K, Singh A, Datta D, Kumar B, Sarkar J. 7-hydroxyfrullanolide, isolated from Sphaeranthus indicus, inhibits colorectal cancer cell growth by p53-dependent and -independent mechanism. Carcinogenesis. 2019;40:791\u2013804. doi: 10.1093/carcin/bgy176.", "ArticleIdList": ["10.1093/carcin/bgy176", "30535334"]}, {"Citation": "Parker AL, Kavallaris M, McCarroll JA. Microtubules and their role in cellular stress in cancer. Frontiers in Oncology. 2014;4:153. doi: 10.3389/fonc.2014.00153.", "ArticleIdList": ["10.3389/fonc.2014.00153", "PMC4061531", "24995158"]}, {"Citation": "Petsalaki E, Zachos G. DNA damage response proteins regulating mitotic cell division: double agents preserving genome stability. The FEBS Journal. 2020;287:1700\u20131721. doi: 10.1111/febs.15240.", "ArticleIdList": ["10.1111/febs.15240", "32027459"]}, {"Citation": "Piccolo M, Misso G, Ferraro MG, Riccardi C, Capuozzo A, Zarone MR, Maione F, Trifuoggi M, Stiuso P, D\u2019Errico G, Caraglia M, Paduano L, Montesarchio D, Irace C, Santamaria R. Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer. Scientific Reports. 2019;9:7006. doi: 10.1038/s41598-019-43411-3.", "ArticleIdList": ["10.1038/s41598-019-43411-3", "PMC6505035", "31065032"]}, {"Citation": "Prota AE, Setter J, Waight AB, Bargsten K, Murga J, Diaz JF, Steinmetz MO. Pironetin binds covalently to alpha Cys316 and perturbs a major loop and helix of alpha-tubulin to inhibit microtubule formation. The Journal of Molecular Biology. 2016;428:2981\u20132988. doi: 10.1016/j.jmb.2016.06.023.", "ArticleIdList": ["10.1016/j.jmb.2016.06.023", "27395016"]}, {"Citation": "Rahman STA, Elbashir AA, El-Mukhtar M, Ibrahim MM. Application of spectrophotometric methods for the determination of thiamine (VB1) in pharmaceutical formulations using 7-chloro-4-nitrobenzoxadiazole (NBD-Cl) The Journal of Analytical and Pharmaceutical Research. 2016;2:00018. doi: 10.15406/japlr.2016.02.00018.", "ArticleIdList": ["10.15406/japlr.2016.02.00018"]}, {"Citation": "Rai SS, Wolff J. Localization of the vinblastine-binding site on beta-tubulin. The Journal of Biological Chemistry. 1996;271:14707\u201314711. doi: 10.1074/jbc.271.25.14707.", "ArticleIdList": ["10.1074/jbc.271.25.14707", "8663038"]}, {"Citation": "Robinson TJ, Liu JC, Vizeacoumar F, Sun T, Maclean N, Egan SE, Schimmer AD, Datti A, Zacksenhaus E. RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugs. PLOS ONE. 2013;8:e78641. doi: 10.1371/journal.pone.0078641.", "ArticleIdList": ["10.1371/journal.pone.0078641", "PMC3827056", "24265703"]}, {"Citation": "Ruangrungsi N, Kasiwong S, Likhitwitayawuid K, Lange GL, Decicco CP. Constituents of Grangea maderaspatana. a new eudesmanolide. The Journal of Natural Products. 1989;52:130\u2013134. doi: 10.1021/np50061a016.", "ArticleIdList": ["10.1021/np50061a016"]}, {"Citation": "Saechan C, Nguyen UH, Wang Z, Sugimoto S, Yamano Y, Matsunami K, Otsuka H, Phan GM, Pham VH, Tipmanee V, Kaewsrichan J. Potency of bisresorcinol from Heliciopsis terminalis on skin aging: in vitro bioactivities and molecular interactions. PeerJ. 2021;9:e11618. doi: 10.7717/peerj.11618.", "ArticleIdList": ["10.7717/peerj.11618", "PMC8231342", "34221723"]}, {"Citation": "Sato M, Toda T. Reconstruction of microtubules: entry into interphase. Developmental Cell. 2004;6:456\u2013458. doi: 10.1016/S1534-5807(04)00101-7.", "ArticleIdList": ["10.1016/S1534-5807(04)00101-7", "15068784"]}, {"Citation": "Schmidt M, Rohe A, Platzer C, Najjar A, Erdmann F, Sippl W. Regulation of G2/M transition by inhibition of WEE1 and PKMYT1 kinases. Molecules. 2017;22:2045. doi: 10.3390/molecules22122045.", "ArticleIdList": ["10.3390/molecules22122045", "PMC6149964", "29168755"]}, {"Citation": "Sharma P. Biology and management of patients with triple-negative breast cancer. Oncologist. 2016;21:1050\u20131062. doi: 10.1634/theoncologist.2016-0067.", "ArticleIdList": ["10.1634/theoncologist.2016-0067", "PMC5016071", "27401886"]}, {"Citation": "Sharma P. Update on the treatment of early-stage triple-negative breast cancer. Current Treatment Options in Oncology. 2018;19:22. doi: 10.1007/s11864-018-0539-8.", "ArticleIdList": ["10.1007/s11864-018-0539-8", "29656345"]}, {"Citation": "Sharma A, Singh K, Almasan A. Histone H2AX phosphorylation: a marker for DNA damage. Methods in Molecular Biology. 2012;920:613\u2013626. doi: 10.1007/978-1-61779-998-3_40.", "ArticleIdList": ["10.1007/978-1-61779-998-3_40", "22941631"]}, {"Citation": "Steinbruck L, Pereira G, Efferth T. Effects of artesunate on cytokinesis and G(2)/M cell cycle progression of tumour cells and budding yeast. Cancer Genomics Proteomics. 2010;7:337\u2013346.", "ArticleIdList": ["21156967"]}, {"Citation": "Steinmetz MO, Prota AE. Microtubule-targeting agents: strategies to hijack the cytoskeleton. Trends in Cell Biology. 2018;28:776\u2013792. doi: 10.1016/j.tcb.2018.05.001.", "ArticleIdList": ["10.1016/j.tcb.2018.05.001", "29871823"]}, {"Citation": "Sudakin V, Chan GK, Yen TJ. Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. The Journal of Cell Biology. 2001;154:925\u2013936. doi: 10.1083/jcb.200102093.", "ArticleIdList": ["10.1083/jcb.200102093", "PMC2196190", "11535616"]}, {"Citation": "Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Syred HM, Welburn J, Rappsilber J, Ohkura H. Cell cycle regulation of microtubule interactomes: multi-layered regulation is critical for the interphase/mitosis transition. Molecular and Cellular Proteomics. 2013;12:3135\u20133147. doi: 10.1074/mcp.M113.028563.", "ArticleIdList": ["10.1074/mcp.M113.028563", "PMC3820929", "23893837"]}, {"Citation": "Tischer J, Gergely F. Anti-mitotic therapies in cancer. The Journal of Cell Biology. 2019;218:10\u201311. doi: 10.1083/jcb.201808077.", "ArticleIdList": ["10.1083/jcb.201808077", "PMC6314557", "30545842"]}, {"Citation": "Uppatanpreecha P. M.Sc. Thesis. 2009. Topoisomerase I inhibitory activity from Thai medicinal plants in yeast cell-based assay."}, {"Citation": "Usui T, Watanabe H, Nakayama H, Tada Y, Kanoh N, Kondoh M, Asao T, Takio K, Watanabe H, Nishikawa K, Kitahara T, Osada H. The anticancer natural product pironetin selectively targets Lys352 of alpha-tubulin. Chemistry & Biology. 2004;11:799\u2013806. doi: 10.1016/j.chembiol.2004.03.028.", "ArticleIdList": ["10.1016/j.chembiol.2004.03.028", "15217613"]}, {"Citation": "Wang C, Kar S, Lai X, Cai W, Arfuso F, Sethi G, Lobie PE, Goh BC, Lim LHK, Hartman M, Chan CW, Lee SC, Tan SH, Kumar AP. Triple negative breast cancer in Asia: an insider\u2019s view. Cancer Treatment Reviews. 2018;62:29\u201338. doi: 10.1016/j.ctrv.2017.10.014.", "ArticleIdList": ["10.1016/j.ctrv.2017.10.014", "29154023"]}, {"Citation": "Whipple RA, Vitolo MI, Boggs AE, Charpentier MS, Thompson K, Martin SS. Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-kappa B inhibition. Breast Cancer Research. 2013;15:R83. doi: 10.1186/bcr3477.", "ArticleIdList": ["10.1186/bcr3477", "PMC3979133", "24028602"]}, {"Citation": "Yang NJ, Hinner MJ. Getting across the cell membrane: an overview for small molecules, peptides, and proteins. Methods in Molecular Biology. 2015;1266:29\u201353. doi: 10.1007/978-1-4939-2272-7_3.", "ArticleIdList": ["10.1007/978-1-4939-2272-7_3", "PMC4891184", "25560066"]}, {"Citation": "Yang J, Wang Y, Wang T, Jiang J, Botting CH, Liu H, Chen Q, Yang J, Naismith JH, Zhu X, Chen L. Pironetin reacts covalently with cysteine-316 of \u03b1-tubulin to destabilize microtubule. Nature Communications. 2016;7:12103. doi: 10.1038/ncomms12103.", "ArticleIdList": ["10.1038/ncomms12103", "PMC4931326", "27357539"]}, {"Citation": "Yin L, Duan J-J, Bian X-W, Yu S-C. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Research. 2020;22:61. doi: 10.1186/s13058-020-01296-5.", "ArticleIdList": ["10.1186/s13058-020-01296-5", "PMC7285581", "32517735"]}, {"Citation": "Zannini L, Delia D, Buscemi G. CHK2 kinase in the DNA damage response and beyond. The Journal of Molecular Cell Biology. 2014;6:442\u2013457. doi: 10.1093/jmcb/mju045.", "ArticleIdList": ["10.1093/jmcb/mju045", "PMC4296918", "25404613"]}, {"Citation": "Zhu H. Cell proliferation assay by flow cytometry (BrdU and PI staining) Bioprotocol. 2012;2:e198. doi: 10.21769/BioProtoc.198.", "ArticleIdList": ["10.21769/BioProtoc.198"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "17"}, {"Year": "2022", "Month": "5", "Day": "6"}, {"Year": "2022", "Month": "6", "Day": "2", "Hour": "2", "Minute": "10"}, {"Year": "2022", "Month": "6", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "3", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "5", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["35651747", "PMC9150694", "10.7717/peerj.13508", "13508"]}}], "PubmedBookArticle": []}